tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ELVN Stock Latest News

Buy Rating for Enliven Therapeutics Driven by Promising Market Dynamics and Growth Prospects
RatingsBuy Rating for Enliven Therapeutics Driven by Promising Market Dynamics and Growth Prospects
1M ago
ELVN
Enliven price target raised to $39 from $37 at H.C. Wainwright
PremiumThe Fly
Enliven price target raised to $39 from $37 at H.C. Wainwright
1M ago
ELVN
Enliven Therapeutics: Promising Developments and Strategic Plans Justify Buy Rating
PremiumRatings
Enliven Therapeutics: Promising Developments and Strategic Plans Justify Buy Rating
1M ago
ELVN
Enliven Therapeutics: Promising Pipeline and Financial Stability Drive Buy Rating
PremiumRatings
Enliven Therapeutics: Promising Pipeline and Financial Stability Drive Buy Rating
1M ago
ELVN
Enliven Therapeutics: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
PremiumRatings
Enliven Therapeutics: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
1M ago
ELVN
Enliven Therapeutics Reports 2024 Financial Results
PremiumCompany AnnouncementsEnliven Therapeutics Reports 2024 Financial Results
1M ago
ELVN
Enliven Therapeutics: Promising Innovations in Tyrosine Kinase Inhibitors and Strategic Growth Plans Justify Buy Rating
Premium
Ratings
Enliven Therapeutics: Promising Innovations in Tyrosine Kinase Inhibitors and Strategic Growth Plans Justify Buy Rating
3M ago
ELVN
Strong Buy Recommendation for Enliven Therapeutics Due to ELVN-001’s High Selectivity and Promising Clinical Data
Premium
Ratings
Strong Buy Recommendation for Enliven Therapeutics Due to ELVN-001’s High Selectivity and Promising Clinical Data
3M ago
ELVN
Enliven initiated with a Buy at BTIG
PremiumThe Fly
Enliven initiated with a Buy at BTIG
4M ago
ELVN
Enliven price target raised to $40 from $32 at Baird
PremiumThe Fly
Enliven price target raised to $40 from $32 at Baird
5M ago
ELVN
Enliven Therapeutics Reports Q3 Results and Clinical Progress
PremiumCompany Announcements
Enliven Therapeutics Reports Q3 Results and Clinical Progress
5M ago
ELVN
Enliven initiated with a Buy at JonesResearch
PremiumThe Fly
Enliven initiated with a Buy at JonesResearch
6M ago
ELVN
Enliven initiated with a Buy at H.C. Wainwright
PremiumThe FlyEnliven initiated with a Buy at H.C. Wainwright
8M ago
ELVN
Enliven price target raised to $39 from $34 at Mizuho
Premium
The Fly
Enliven price target raised to $39 from $34 at Mizuho
8M ago
ELVN
Enliven reports Q2 EPS (41c), consensus (55c)
Premium
The Fly
Enliven reports Q2 EPS (41c), consensus (55c)
9M ago
ELVN
Enliven initiated with an Outperform at Baird
PremiumThe Fly
Enliven initiated with an Outperform at Baird
11M ago
ELVN
Short Report: GameStop, AMC Entertainment bears retreat further
PremiumThe Fly
Short Report: GameStop, AMC Entertainment bears retreat further
11M ago
GME
SMR
Enliven reports Q1 EPS (54c), consensus (57c)
PremiumThe Fly
Enliven reports Q1 EPS (54c), consensus (57c)
12M ago
ELVN
Enliven files to sell 6.43M shares of common stock for holders
PremiumThe Fly
Enliven files to sell 6.43M shares of common stock for holders
1y ago
ELVN
Short Report: Bears reduce exposure to Kohl’s as stock momentum fizzles
PremiumThe FlyShort Report: Bears reduce exposure to Kohl’s as stock momentum fizzles
1y ago
KSS
ELVN
Enliven announces proof of concept data from Phase 1 trial of ELVN-001
Premium
The Fly
Enliven announces proof of concept data from Phase 1 trial of ELVN-001
1y ago
ELVN
Enliven to hold a conference call
Premium
The Fly
Enliven to hold a conference call
1y ago
ELVN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >